A Phase III, Multicenter, Randomized, Open-label Study of Oral LDK378 Versus Standard Chemotherapy in Adult Patients With ALK-rearranged (ALK-positive) Advanced Non-small Cell Lung Cancer Who Have Been Treated Previously With Chemotherapy (Platinum Doublet) and Crizotinib
Latest Information Update: 26 Aug 2024
At a glance
- Drugs Ceritinib (Primary) ; Docetaxel; Pemetrexed
- Indications Non-small cell lung cancer
- Focus Registrational; Therapeutic Use
- Acronyms ASCEND V
- Sponsors Novartis; Novartis Pharmaceuticals
- 20 Dec 2023 This trial has been completed in Belgium, according to European Clinical Trials Database record
- 27 Nov 2023 Status changed from active, no longer recruiting to completed.
- 07 Nov 2023 This trial has been completed in Netherlands, according to European Clinical Trials Database record.